Hematologist Oncologist Akash Mukherjee, M.D., Joins UAMS Stem Cell Transplantation and Cellular Therapy Program

By Susan Van Dusen

He sees patients at the UAMS Winthrop P. Rockefeller Cancer Institute and specializes in allogeneic and autologous stem cell transplantation. Allogeneic stem cell transplantation involves transplanting healthy stem cells obtained from a donor to treat patients with lymphomas, leukemias and other blood disorders. Autologous transplants involve collecting stem cells from a patient’s own bone marrow or blood to be infused into the patient and is used to treat multiple myeloma, relapsed lymphoma and other blood disorders.

He also specializes in CAR-T cellular therapy used to treat various malignant hematological disorders.

Mukherjee serves as an assistant professor in the UAMS College of Medicine Division of Hematology/Oncology.

After graduating from Maulana Azad Medical College in New Delhi, India, one of the country’s premier medical schools, Mukherjee completed his residency in internal medicine at Georgetown University/Washington Hospital Center in Washington, D.C.

He received specialized training in two fellowship programs: the three-year Hematology-Oncology Fellowship at Houston Methodist Hospital, where he served as chief fellow, and the one-year Stem Cell Transplantation and Cellular Therapy Fellowship at MD Anderson Cancer Center in Houston.

Mukherjee’s research examines the clinical outcomes of allogeneic transplant patients, including factors such as post-transplant hemorrhagic cystitis, pretransplant use of novel small molecule inhibitors in acute leukemia and lymphoma, clinical outcome of post-transplant cyclophosphamide-based haploidentical stem cell transplant in lymphoma patients, in vivo anti-thymocyte globulin based matched unrelated donor transplant, and post allogeneic transplant iron overload, among other areas.

He is board certified in hematology, oncology and internal medicine and is a member of the American College of Physicians, American Society of Hematology, American Society of Clinical Oncology and American Society of Bone Marrow Transplantation.

The UAMS Stem Cell Transplantation and Cellular Therapy Program is accredited by the Foundation for the Accreditation of Cellular Therapy and is Arkansas’ only adult transplant program of its type.

UAMS is the state’s only health sciences university, with colleges of Medicine, Nursing, Pharmacy, Health Professions and Public Health; a graduate school; a hospital; a main campus in Little Rock; a Northwest Arkansas regional campus in Fayetteville; a statewide network of regional campuses; and eight institutes: the Winthrop P. Rockefeller Cancer Institute, Jackson T. Stephens Spine & Neurosciences Institute, Harvey & Bernice Jones Eye Institute, Psychiatric Research Institute, Donald W. Reynolds Institute on Aging, Translational Research Institute, Institute for Digital Health & Innovation and the Institute for Community Health Innovation. UAMS includes UAMS Health, a statewide health system that encompasses all of UAMS’ clinical enterprise. UAMS is the only adult Level 1 trauma center in the state. UAMS has 3,275 students, 890 medical residents and fellows, and five dental residents. It is the state’s largest public employer with more than 12,000 employees, including 1,200 physicians who provide care to patients at UAMS, its regional campuses, Arkansas Children’s, the VA Medical Center and Baptist Health. Visit www.uams.edu or uamshealth.com. Find us on Facebook, X (formerly Twitter), YouTube or Instagram.